Quince Therapeutics, Inc.
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2018 | 3.4M |
| FY2019 | 26.9M |
| FY2020 | 29.5M |
| FY2021 | 29.7M |
| FY2022 | 33.5M |
| FY2023 | 37.2M |
| FY2024 | 43.3M |
| FY2025 | 50.1M |
| FY2026 | 163.0M |
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2018 | 3.4M |
| FY2019 | 26.9M |
| FY2020 | 29.5M |
| FY2021 | 29.7M |
| FY2022 | 33.5M |
| FY2023 | 37.2M |
| FY2024 | 43.3M |
| FY2025 | 50.1M |
| FY2026 | 163.0M |